Enanta Pharmaceuticals Newsroom

H.C. Wainwright Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $27

Moomoo NewsOct 10 06:31 ET

JMP Securities Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsOct 9 01:31 ET

Buy Rating for Enanta Pharmaceuticals Amid Reduced Competition and Promising Drug Trials

TipRanksOct 9 00:57 ET

Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Resmed (RMD)

TipRanksSep 27 13:32 ET

Leerink Partners Maintains Enanta Pharmaceuticals(ENTA.US) With Hold Rating

Moomoo NewsSep 27 13:31 ET

Baird Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $26

Moomoo NewsSep 27 13:31 ET

Enanta Pharmaceuticals (ENTA) Gets a Hold From Leerink Partners

TipRanksSep 27 13:19 ET

Enanta Pharma Analyst Ratings

BenzingaSep 27 10:50 ET

JMP Securities Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsSep 27 01:32 ET

JMP Securities Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsSep 26 16:32 ET

Enanta Pharmaceuticals Gains Buy Rating on Strong Clinical Results for EDP-323

TipRanksSep 26 16:20 ET

Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA), Hyperfine (HYPR) and Biogen (BIIB)

TipRanksAug 11 13:03 ET

Enanta Pharmaceuticals: Hold Rating Amid RSV Pipeline Progress and Financial Caution

TipRanksAug 7 02:22 ET

Buy Rating Affirmed on Enanta Pharmaceuticals' Promising Drug Pipeline and Strategic Expansion Into Immunology

TipRanksAug 7 01:45 ET

Evercore Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsAug 6 08:31 ET

H.C. Wainwright Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $27

Moomoo NewsAug 6 06:31 ET

Enanta Pharmaceuticals: Promising Pipeline Progress and a Buy Rating

TipRanksAug 6 06:29 ET

JMP Securities Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsAug 6 00:32 ET

Buy Rating Affirmed for Enanta Pharmaceuticals Amid Promising Clinical Developments and Robust Financial Health

TipRanksAug 6 00:27 ET

Hold Rating on Enanta Pharmaceuticals Amidst Clinical Trials Uncertainty and Financial Outlook

TipRanksMay 8 00:00 ET